Tracking newborns with positive screening tests
Part of Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This study follows babies who had a positive newborn screening test for severe combined immunodeficiency (SCID), a rare condition affecting the immune system. The goal is to monitor their health over time to better understand and manage the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby had a positive newborn screening test (Guthrie test) for SCID.
- The positive result was confirmed by a blood test (lymphocyte immunophenotyping) at a pediatric specialist visit.
- Your family has not objected to participating in this study after receiving information about it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children and adults with SCID and related immune disorders to understand how the illness behaves over time. It also helps researchers learn which testing results and genetic types of SCID match different treatment plans.
This study looks at what it feels like for people to go through screening for SCID (a rare immune condition). It may help improve the screening process and support for patients and families.
This study tests a screening program to detect inherited blood disorders in newborns at higher risk. Early detection can help manage treatment sooner.
This study screens people who may have an inherited immune system condition (like problems with immune cell growth or death) and their blood relatives. The goal is to understand the condition better by collecting blood samples for testing.
This study tests a simple blood test for newborn babies to find sickle cell disease early. If the test shows your baby has it, they can get care right away to stay healthier.
This study tests a new way to screen newborns for rare genetic diseases using a blood sample. It aims to find treatable conditions early so that babies can get care sooner.
Hear when a new Severe Combined Immunodeficiencies (SCID) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.